XOMA There are 3 IL-1 inhibitors on the market associated with the ligand/receptor signaling interaction, anakinra (Kineret; Amgen/Biovitrum), canakinumab (Ilaris; Novartis) and rilonacept (Arcalyst; Regeneron). Anakinra and rilonacept inhibits the effect of IL-1alpha as well as those of beta. As I understand it, diacerein/rhein prevents, the formation of IL-1beta and not the receptors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.